Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques the Copenhagen City Heart Study

European Heart Journal

Volumn 24, Issue 6, 2003, Pages 567-576

  Kofoed, S C ^a   Wittrup, H H ^a   Sillesen, H ^a   Nordestgaard, B G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Atherosclerosis; Carotid disease; Follow up study; Stroke; Ultrasonics

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; ULTRASOUND;

EID: 0345535125     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00467-0     Document Type: Article

References (28)

1. Withetmsen L, Svardsudd K, Korsan-Bengtsen K et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
2. Stone MC, Thorp JM. Plasma fibrinogen-a major coronary risk factor. J R Coll Gen Pract 1985;35:565-9.
3. Kannel WB, Wolf PA, Castelli WP et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258:1183-6.
4. Heinrich J, Batteisen L, Schulte H et al. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14:54-9.
5. Yarnell JW, Baker IA, Sweetnam PM et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83:836-44.
6. Ridker PM, Hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-43.
7. Ridker PM, Buring JE, Shih J et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-3.
8. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
9. Ross R. Atheroscierosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
10. Giral P, Bruckert E, Dairou F et al. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress tests. Am J Cardiol 1999;84:14-7.
11. Bergmark C, Jogestrand T, Swedenborg J. Carotid atherosclerosis in patients operated for lower extremity ischemia before the age of 50: a case control study. Ann Vasc Surg 1998;12:430-5.
12. El-Barghouty NM, Levine T, Ladva S et al. Histological verification of computerised carotid plaque characterisation. Eur J Vasc Endovasc Surg 1996;11:414-6.
13. Gronholdt M-LM, Nordestgaard BG, Wiebe BM et al. Echolucency of computerised ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well increased plaque lipid content. Circulation 1998;97:34-40.
14. Ravn HB, Falk E. Histopathology of plaque rupture. Cardiol Clin 1999;17:263-70.
15. Polak JF, Shemanski L, O'Leary DH et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998;208:649-54.
16. Gronholdt ML, Nordestgaard BG, Schroeder TV et al. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001;104:68-73.
17. Sethi AA, Tybjaerg-Hansen A, Gronholdt ML et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 2001;134:941-54.
18. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE et al. A common mutation (G-455→A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997;99:3034-9.
19. Agerholm-Larsen B, Tybjaerg-Hansen A, Frikke-Schmidt R et al. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med 1997;127:346-55.
20. Londrey GL, Spadone DP, Hodgson KJ et al. Does color-flow imaging improve the accuracy of duplex carotid evaluation? J Vasc Surg 1991;13:659-63.
21. Guidelines Subcommittee. World Health Organization- International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.
22. Tracy RP, Arnold AM, Ettinger W et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999;19:1776-83.
23. Folsom AR, Rosamond WD, Shahar E. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999;100:736-42.
24. Smith FB, Lee AJ, Fowkes FG et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17:3321-5.
25. Levenson J, Giral P, Razavian M et al. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 1995;15:1263-8.
26. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
27. Zwaka TP, Hombach V, Torzewski J. C-reactive protein- mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103: 1194-7.
28. Hashimoto H, Kitagawa K, Hougaku H et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001;104:63-7.